Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments

Figure 2

Epidermal immunostaining for AGE: patient 4 before (a) and after SKPT (b); patient 8 before (c) and after SKPT (d); patient 10 before (e) and after SKPT (f); patient 11 before (g) and after SKPT (h) (400x amplified, hematoxylin counterstained). Images showing the main immunostaining changes, from a diffuse cytoplasmic to an interkeratinocytic or peripheral pattern, often less intense, at time of 12 months.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)